miR‐15a‐5p and miR‐21‐5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2-Reference-Cited by-同舟云学术

miR‐15a‐5p and miR‐21‐5p contribute to chemoresistance in cytogenetically normal acute myeloid leukaemia by targeting PDCD4, ARL2 and BTG2

Published:2020-12-03 Issue:1 Volume:25 Page:575-585
ISSN:1582-1838
Container-title:Journal of Cellular and Molecular Medicine
language:en
Short-container-title:J. Cell. Mol. Med.

Author:

Vandewalle Virginie¹²,Essaghir Ahmed²,Bollaert Emeline²,Lenglez Sandrine²,Graux Carlos³,Schoemans Hélène⁴,Saussoy Pascale⁵,Michaux Lucienne⁶,Valk Peter J. M.⁷,Demoulin Jean‐Baptiste²,Havelange Violaine¹²^ORCID

Affiliation:

1. Department of Hematology Cliniques Universitaires Saint‐Luc Brussels Belgium

2. Experimental Medicine Unit de Duve Institute Université Catholique de Louvain Brussels Belgium

3. Department of Hematology CHU UCL Namur (Godinne site) Yvoir Belgium

4. Department of Hematology University Hospitals Leuven and KU Leuven Leuven Belgium

5. Laboratory of Hematology Cliniques Universitaires Saint Luc Brussels Belgium

6. Center for Human Genetics University Hospitals Leuven and KU Leuven Leuven Belgium

7. Department of Hematology Erasmus University Medical Center Rotterdam the Netherlands

Funder

Fonds De La Recherche Scientifique - FNRS

Stichting Tegen Kanker

Koning Boudewijnstichting

Publisher

Wiley

Subject

Cell Biology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcmm.16110

Reference35 articles.

1. Treatment, trial participation and survival in adult acute myeloid leukemia: a population-based study in the Netherlands, 1989–2012

2. Acute Myeloid Leukemia

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

4. An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

5. AML refractory to primary induction with Ida-FLAG has a poor clinical outcome

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miR-149-3p Enhances Drug Sensitivity of AML Cells by Inhibiting Warburg Effect Through PI3K/AKT Pathway;Cell Biochemistry and Biophysics;2024-08-17

2. MicroRNA-21a-5p inhibition alleviates systemic sclerosis by targeting STAT3 signaling;Journal of Translational Medicine;2024-04-01

3. Exploring risk factors and molecular targets in leukemia patients with COVID-19: a bioinformatics analysis of differential gene expression;Journal of Leukocyte Biology;2024-02-07

4. MicroRNAs Associated with a Bad Prognosis in Acute Myeloid Leukemia and Their Impact on Macrophage Polarization;Biomedicines;2024-01-07

5. The impact of microRNAs on the resistance of breast cancer subtypes to chemotherapy;Pathology - Research and Practice;2023-09